Medical Developments International Limited (FRA:M5D)

Market Cap	31.53M -20.8%
Revenue (ttm)	25.78M +9.0%
Net Income	379.07K +566.0%
EPS	0.00 +562.4%
Shares Out	n/a
PE Ratio	83.18
Forward PE	36.61
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.2380
Previous Close	0.2820
Day's Range	0.2380 - 0.2380
52-Week Range	0.0100 - 0.3180
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 20, 2026

About FRA:M5D

Medical Developments International Limited provides emergency medical solutions in Australia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It manufactures and distributes Penthrox, a fast-acting trauma and emergency pain relief product used in hospital emergency departments, ambulance services, sports medicine, and for analgesia during short surgical procedures. The company also supplies respiratory products, including space chambers, peak flow meters, portable nebulizers...

• Industry: Pharmaceutical Preparations
• Founded: 1972
• Employees: 68
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: M5D

Financial Performance

In fiscal year 2026, FRA:M5D's revenue was 42.57 million, an increase of 8.99% compared to the previous year's 39.06 million. Earnings were 626,000, an increase of 565.96%.

Financial numbers in AUD

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 27, 2026

Data Sources Report a data error